Nemaura Medical Free Cash Flow 2014-2023 | NMRD
Nemaura Medical free cash flow from 2014 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Nemaura Medical Annual Free Cash Flow | |
|---|---|
| 2023 | -8.99 |
| 2022 | -7.46 |
| 2021 | -6.84 |
| 2020 | -3.66 |
| 2019 | -3.64 |
| 2018 | -2.18 |
| 2017 | -1.27 |
| 2016 | -1.22 |
| 2015 | -1.45 |
| 2014 | 1.51 |
| Nemaura Medical Quarterly Free Cash Flow | |
|---|---|
| 2023-12-31 | -7.28 |
| 2023-09-30 | -5.79 |
| 2023-06-30 | -2.55 |
| 2023-03-31 | -8.99 |
| 2022-12-31 | -6.53 |
| 2022-09-30 | -4.93 |
| 2022-06-30 | -2.60 |
| 2022-03-31 | -7.46 |
| 2021-12-31 | -5.23 |
| 2021-09-30 | -4.16 |
| 2021-06-30 | -2.09 |
| 2021-03-31 | -6.84 |
| 2020-12-31 | -5.20 |
| 2020-09-30 | -3.05 |
| 2020-06-30 | -1.09 |
| 2020-03-31 | -3.66 |
| 2019-12-31 | -2.78 |
| 2019-09-30 | -2.03 |
| 2019-06-30 | -0.78 |
| 2019-03-31 | -3.64 |
| 2018-12-31 | -2.38 |
| 2018-09-30 | -1.55 |
| 2018-06-30 | -0.45 |
| 2018-03-31 | -2.18 |
| 2017-12-31 | -1.29 |
| 2017-09-30 | -0.99 |
| 2017-06-30 | -0.30 |
| 2017-03-31 | -1.27 |
| 2016-12-31 | -0.71 |
| 2016-09-30 | -0.51 |
| 2016-06-30 | -0.22 |
| 2016-03-31 | -1.22 |
| 2015-12-31 | -0.69 |
| 2015-09-30 | -0.46 |
| 2015-06-30 | -0.18 |
| 2015-03-31 | -1.45 |
| 2014-12-31 | -1.30 |
| 2014-09-30 | -1.04 |
| 2014-06-30 | -0.77 |
| 2014-03-31 | 1.51 |
| 2013-12-31 | -0.21 |
| 2013-09-30 | -0.16 |
| 2013-06-30 | -0.17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.002B | $0.000B |
| Nemaura Medical Inc. is a medical technology company. It engages in developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT(R), BEAT(TM) diabetes, and proBEAT(TM). SugarBEAT(R), a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor. Nemaura Medical Inc. is based in New York, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $226.743B | 27.48 |
| Intuitive Surgical (ISRG) | United States | $141.891B | 85.48 |
| Edwards Lifesciences (EW) | United States | $54.101B | 35.21 |
| DexCom (DXCM) | United States | $51.973B | 78.73 |
| IDEXX Laboratories (IDXX) | United States | $43.777B | 51.31 |
| Alcon (ALC) | Switzerland | $43.442B | 31.13 |
| IQVIA Holdings (IQV) | United States | $41.922B | 24.32 |
| STERIS (STE) | Ireland | $22.999B | 26.88 |
| Waters (WAT) | United States | $21.000B | 30.86 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.908B | 0.00 |
| Hologic (HOLX) | United States | $17.468B | 19.54 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.869B | 15.02 |
| ShockWave Medical (SWAV) | United States | $12.384B | 77.07 |
| Sysmex ADR (SSMXY) | Japan | $11.134B | 34.91 |
| Teleflex (TFX) | United States | $10.108B | 15.73 |
| Globus Medical (GMED) | United States | $8.970B | 26.29 |
| Penumbra (PEN) | United States | $7.809B | 88.74 |
| Masimo (MASI) | United States | $6.723B | 38.73 |
| Glaukos (GKOS) | United States | $5.504B | 0.00 |
| TransMedics (TMDX) | United States | $4.566B | 433.19 |
| Integer Holdings (ITGR) | United States | $4.029B | 24.34 |
| PROCEPT BioRobotics (PRCT) | United States | $3.533B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.318B | 19.70 |
| Tandem Diabetes Care (TNDM) | United States | $3.051B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.973B | 20.40 |
| Inari Medical (NARI) | United States | $2.682B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.474B | 20.92 |
| RxSight (RXST) | United States | $2.317B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.126B | 9.27 |
| Veracyte (VCYT) | United States | $1.705B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.543B | 0.00 |
| Artivion (AORT) | United States | $0.993B | 95.24 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.933B | 18.14 |
| OPKO Health (OPK) | United States | $0.920B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.897B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.775B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.656B | 22.26 |
| Paragon 28 (FNA) | United States | $0.621B | 0.00 |
| SiBone (SIBN) | United States | $0.593B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.567B | 0.00 |
| IRadimed (IRMD) | United States | $0.555B | 31.07 |
| Pacific Biosciences Of California (PACB) | United States | $0.523B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.474B | 0.00 |
| Nevro (NVRO) | United States | $0.386B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.324B | 11.10 |
| Treace Medical Concepts (TMCI) | United States | $0.306B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.282B | 0.00 |
| AxoGen (AXGN) | United States | $0.271B | 0.00 |
| 908 Devices (MASS) | United States | $0.236B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.233B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.231B | 0.00 |
| NeuroPace (NPCE) | United States | $0.230B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.223B | 0.00 |
| Inogen (INGN) | United States | $0.207B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.201B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.189B | 0.00 |
| CVRx (CVRX) | United States | $0.179B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.168B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.166B | 8.42 |
| Accuray (ARAY) | United States | $0.159B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.108B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.103B | 21.59 |
| KORU Medical Systems (KRMD) | United States | $0.101B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.091B | 0.00 |
| Neuronetics (STIM) | United States | $0.076B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Hyperfine (HYPR) | United States | $0.065B | 0.00 |
| Envoy Medical (COCH) | United States | $0.064B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | Israel | $0.057B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.056B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.054B | 0.00 |
| DarioHealth (DRIO) | United States | $0.053B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.048B | 0.00 |
| LENSAR (LNSR) | United States | $0.046B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.043B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.040B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.032B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.028B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.024B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.020B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |